Cargando…

Ewing sarcoma in a child with neurofibromatosis type 1

We report here on a case of Ewing sarcoma (ES) occurring in a child with neurofibromatosis type 1. The sarcoma had an EWSR1-ERG translocation as well as loss of the remaining wild-type allele of NF1. Loss of the NF1 wild-type allele in the tumor suggests that activation of the Ras pathway contribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Karen S., Turski, Michelle L., Shah, Avanthi Tayi, Bastian, Boris C., Horvai, Andrew, Hardee, Steven, Sweet-Cordero, E. Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824249/
https://www.ncbi.nlm.nih.gov/pubmed/31645347
http://dx.doi.org/10.1101/mcs.a004580
Descripción
Sumario:We report here on a case of Ewing sarcoma (ES) occurring in a child with neurofibromatosis type 1. The sarcoma had an EWSR1-ERG translocation as well as loss of the remaining wild-type allele of NF1. Loss of the NF1 wild-type allele in the tumor suggests that activation of the Ras pathway contributed to its evolution. Review of available public data suggests that secondary mutations in the Ras pathway are found in ∼3% of ESs. This case suggests that Ras pathway activation may play a role in tumor progression in a subset of ESs.